141 related articles for article (PubMed ID: 34915831)
1. Evaluation of Nigerian Medicinal Plants Extract on Human P-glycoprotein and Cytochrome P450 Enzyme Induction: Implications for Herb-drug Interaction.
Amaeze O; Marques ES; Wei W; Lazzaro S; Johnson N; Varma MVS; Slitt A
Curr Drug Metab; 2021; 22(14):1103-1113. PubMed ID: 34915831
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 Enzyme Inhibition and Herb-Drug Interaction Potential of Medicinal Plant Extracts Used for Management of Diabetes in Nigeria.
Amaeze O; Eng H; Horlbogen L; Varma MVS; Slitt A
Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):437-450. PubMed ID: 33844145
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Cytochrome P450, P-glycoprotein and Pregnane X Receptor by Selected Antimalarial Herbs-Implication for Herb-Drug Interaction.
Fasinu PS; Manda VK; Dale OR; Egiebor NO; Walker LA; Khan SI
Molecules; 2017 Nov; 22(12):. PubMed ID: 29168799
[TBL] [Abstract][Full Text] [Related]
4. Investigation of CYP2B6, 3A4 and β-esterase interactions of Withania somnifera (L.) dunal in human liver microsomes and HepG2 cells.
Kumar S; Bouic PJ; Rosenkranz B
J Ethnopharmacol; 2021 Apr; 270():113766. PubMed ID: 33395575
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.
Fasinu PS; Bouic PJ; Rosenkranz B
Afr J Tradit Complement Altern Med; 2014; 11(4):54-61. PubMed ID: 25392581
[TBL] [Abstract][Full Text] [Related]
6. Screening of medicinal plants for possible herb-drug interactions through modulating nuclear receptors, drug-metabolizing enzymes and transporters.
Husain I; Dale OR; Martin K; Gurley BJ; Adams SJ; Avula B; Chittiboyina AG; Khan IA; Khan SI
J Ethnopharmacol; 2023 Jan; 301():115822. PubMed ID: 36223846
[TBL] [Abstract][Full Text] [Related]
7. The potential of Sutherlandia frutescens for herb-drug interaction.
Fasinu PS; Gutmann H; Schiller H; James AD; Bouic PJ; Rosenkranz B
Drug Metab Dispos; 2013 Feb; 41(2):488-97. PubMed ID: 23209194
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 inhibition activities of non-standardized botanical products.
Abduraman MA; Mustafa NH; Yaacob NS; Amanah A; Tan ML
J Ethnopharmacol; 2022 Oct; 296():115406. PubMed ID: 35659627
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Modulation of Glibenclamide Transport by P-glycoprotein Inhibitory Antidiabetic African Plant Extracts.
Ezuruike UF; Chieli E; Prieto JM
Planta Med; 2019 Aug; 85(11-12):987-996. PubMed ID: 31350736
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CYP2B6 by Medicinal Plant Extracts: Implication for Use of Efavirenz and Nevirapine-Based Highly Active Anti-Retroviral Therapy (HAART) in Resource-Limited Settings.
Thomford NE; Awortwe C; Dzobo K; Adu F; Chopera D; Wonkam A; Skelton M; Blackhurst D; Dandara C
Molecules; 2016 Feb; 21(2):. PubMed ID: 26891286
[TBL] [Abstract][Full Text] [Related]
12. Metabolism-mediated drug interaction potential of HS-23, a new herbal drug for the treatment of sepsis in human hepatocytes and liver microsomes.
Jeong HU; Lee JY; Kwon SS; Kim JH; Kim YM; Hong SW; Yeon SH; Lee SM; Cho YY; Lee HS
Arch Pharm Res; 2015 Feb; 38(2):171-7. PubMed ID: 25052959
[TBL] [Abstract][Full Text] [Related]
13. Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism.
Zhang F; Huang J; He RJ; Wang L; Huo PC; Guan XQ; Fang SQ; Xiang YW; Jia SN; Ge GB
Phytomedicine; 2020 Oct; 77():153287. PubMed ID: 32739573
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
[TBL] [Abstract][Full Text] [Related]
15. The potential of Epimedium koreanum Nakai for herb-drug interaction.
Zhong Q; Shi Z; Zhang L; Zhong R; Xia Z; Wang J; Wu H; Jiang Y; Sun E; Wei Y; Feng L; Zhang Z; Liu D; Song J; Jia X
J Pharm Pharmacol; 2017 Oct; 69(10):1398-1408. PubMed ID: 28653752
[TBL] [Abstract][Full Text] [Related]
16. The effects of Andrographis paniculata (Burm.f.) Nees extract and diterpenoids on the CYP450 isoforms' activities, a review of possible herb-drug interaction risks.
Tan ML; Lim LE
Drug Chem Toxicol; 2015; 38(3):241-53. PubMed ID: 25156015
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening of inhibitory effects of Bo-yang-hwan-o-tang on human cytochrome P450 isoforms in vitro using UPLC/MS/MS.
Lee M; Park J; Lim MS; Seong SJ; Lee J; Seo JJ; Park YK; Lee HW; Yoon YR
Anal Sci; 2012; 28(12):1197-201. PubMed ID: 23232241
[TBL] [Abstract][Full Text] [Related]
18. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes.
Hellum BH; Hu Z; Nilsen OG
Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):23-30. PubMed ID: 17214607
[TBL] [Abstract][Full Text] [Related]
19. Interactions of Papua New Guinea medicinal plant extracts with antiretroviral therapy.
Larson EC; Hathaway LB; Lamb JG; Pond CD; Rai PP; Matainaho TK; Piskaut P; Barrows LR; Franklin MR
J Ethnopharmacol; 2014 Sep; 155(3):1433-40. PubMed ID: 25138353
[TBL] [Abstract][Full Text] [Related]
20. The potential of Hypoxis hemerocallidea for herb-drug interaction.
Fasinu PS; Gutmann H; Schiller H; Bouic PJ; Rosenkranz B
Pharm Biol; 2013 Dec; 51(12):1499-507. PubMed ID: 23844611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]